Hepatitis C virus infections in dialysis centers in The Netherlands: A national survey by serological and molecular methods

Journal of Clinical Microbiology

Volumn 36, Issue 6, 1998, Pages 1711-1715

  Schneeberger, Peter M ^a   Keur, Ingrid ^b   Van Der Vliet, Walter ^c   Van Hoek, Kitty ^c   Boswijk, Henk ^d   Van Loon, Anton M ^e   Van Dijk, Willemien C ^f   Kauffmann, Robert H ^g   Quint, Wim ^c   Van Doorn, Leen Jan ^c  

^a JEROEN BOSCH HOSPITAL   (Netherlands)

^b Diatel Amsterdam   (Netherlands)

^c REINIER DE GRAAF HOSPITAL   (Netherlands)

^d NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^f SLOTERVAART HOSPITAL   (Netherlands)

^g LEYENBURG HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ENZYME IMMUNOASSAY; GENOTYPE; HEMODIALYSIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INCIDENCE; INFECTION RISK; NETHERLANDS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK ASSESSMENT; SCREENING; SERODIAGNOSIS; VIRUS DETECTION;

HEPATITIS C VIRUS; RNA VIRUSES; STAPHYLOCOCCUS PHAGE 3A;

EID: 0031968864     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.36.6.1711-1715.1998     Document Type: Article

References (33)

1. Aach, R. D., C. E. Stevens, F. B. Hollinger, J. W. Mosley, D. A. Peterson, P. E. Taylor, R. G. Johnson, L. H. Barbosa, and G. J. Nemo. 1991. Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays. N. Engl. J. Med. 325:1325-1329.
2. al-Faleh, F. Z., S. Ramia, M. Arif, E. A. Ayoola, R. S. al-Rashed, M. al-Jeffry, A. Hossain, and M. el-Hazmi. 1995. Profile of hepatitis C virus and the possible modes of transmission of the virus in the Gizan area of Saudi Arabia: a community-based study. Ann. Trop. Med. Parasitol. 89:431-437.
3. Allander, T., A. Gruber, M. Naghavi, A. Beyene, T. Soderstrom, M. Bjorkholm, L. Grillner, and M. A. Persson. 1995. Frequent patient-to-patient transmission of hepatitis C virus in a haematology ward. Lancet 345:603-607.
4. Bjoro, K., S. S. Froland, Z. Yun, H. H. Samdal, and T. Haaland. 1994. Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin. N. Engl. J. Med. 331:1607-1611.
5. Bukh, J., P. Wantzin, K. Krogsgaard, F. Knudsen, R. H. Purcell, and R. H. Miller. 1993. High prevalence of hepatitis C virus (HCV) RNA in dialysis patients: failure of commercially available antibody tests to identify a significant number of patients with HCV infection. Copenhagen Dialysis HCV Study Group. J. Infect. Dis. 168:1343-1348.
6. Corcoran, G. D., N. S. Brink, C. G. Millar, J. A. Garson, J. Waite, R. Deaville, F. D. Thompson, and R. S. Tedder. 1994. Hepatitis C virus infection in haemodialysis patients: a clinical and virological study. J. Infect 28:279-285.
7. Darwish, M. A., T. A. Raouf, P. Rushdy, N. T. Constantine, M. R. Rao, and R. Edelman. 1993. Risk factors associated with a high seroprevalence of hepatitis C virus infection in Egyptian blood donors. Am. J. Trop. Med. Hyg. 49:440-447.
8. Fabrizi, F., G. Lunghi, I. Guarnori, L. Raffaele, G. Erba, A. Pagano, and F. Locatelli. 1996. Hepatitis C virus genotypes m chronic dialysis patients. Nephrol. Dial. Transplant. 11:679-683.
9. Fujiyama, S., S. Kawano, S. Sato, H. Shimada, K. Matsushita, N. Ikezaki, T. Nakano, and T. Sato. 1995. Changes in prevalence of anti-HCV antibodies associated with preventive measures among hemodialysis patients and dialysis staff. Hepato-Gastroenterology 42:162-165.
10. Goldbloom, S. E., and W. P. Reed. 1980. Host defenses and immunologic alterations associated with chronic hemodialysis. Ann. Intern. Med. 93:597-613.
11. Huraib, S., R. al-Rashed, A. Aldrees, M. Aljefry, M. Arif, and F. A. al-Faleh. 1995. High prevalence of and risk factors for hepatitis C in haemodialysis patients in Saudi Arabia: a need for new dialysis strategies. Nephrol. Dial. Transplant. 10:470-474.
12. Irie, Y., H. Hayashi, K. Yokozeki, T. Kashima, and K. Okuda. 1994. Hepatitis C infection unrelated to blood transfusion in hemodialysis patients. J. Hepatol. 20:557-559.
13. Jadoul, M., C. Cornu, and C. van Ypersele de Strihou. 1993. Incidence and risk factors for hepatitis C seroconversion in hemodialysis: a prospective study. The UCL Collaborative Group. Kidney Int. 44:1322-1326.
14. Keur, I., P. Schneeberger, Y. Van der Graaf, J. Vos, W. van Dijk, and L. J. van Doorn. 1997. Risk factors for HCV-infection in two dialysis units in the Netherlands. Neth. J. Med. 50:97-101.
15. Kuhns, M., M. De Medina, A. McNamara, L. J. Jeffers, K. R. Reddy, M. Silva, C. Ortiz Interian, M. Jimenez, E. R. Schiff, and G. Perez. 1994. Detection of hepatitis C virus RNA in hemodialysis patients. J. Am. Soc. Nephrol. 4:1491-1497.
16. Kuo, G., Q. L. Choo, H. J. Alter, G. L. Gitnick, A. G. Redeker, R. H. Purcell, T. Miyamura, J. L. Dienstag, M. J. Alter, C. E. Stevens, et al. 1989. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244:362-364.
17. Maertens, G., F. Dekeyser, A. Van Geel, F. Sablon, F. Bosman, M. Zrein, and D. Pollet. Confirmation of HCV-antibodies by line immuno assay INNOLIA HCV Ab III. In J. Y. N. Lau (ed.), Methods in molecular biology: hepatitis C, in press.
18. Pawlotsky, J. M., A. Bastie, C. Pellet, J. Remire, F. Darthuy, L. Wolfe, C. Sayada, J. Duval, and D. Dhumeaux. 1996. Significance of indeterminate third-generation hepatitis C virus recombinant immunoblot assay. J. Clin. Microbiol. 34:80-83.
19. Peters, T., L. Mohr, F. Scheiffele, H. J. Schlayer, S. Preisler, H. Berthold, W. Gerok, and J. Rasenack. 1994. Antibodies and viremia in acute post-transfusion hepatitis C: a prospective study. J. Med. Virol. 42:420-427.
20. Sakamoto, N., N. Enomoto, F. Marumo, and C. Sato. 1993. Prevalence of hepatitis C virus infection among long-term hemodialysis patients: detection of hepatitis C virus RNA in plasma. J. Med. Virol. 39:11-15.
21. Sampietro, M., S. Badalamenti, S. Salvadori, N. Corbetta, G. Graziani, G. Como, G. Fiorelli, and C. Ponticelli. 1995. High prevalence of a rare hepatitis C virus in patients treated in the same hemodialysis unit: evidence for nosocomial transmission of HCV. Kidney Int. 47:911-917.
22. Schlipkoter, U., U. Gladziwa, K. Cholmakov, A. Weise, R. Rasshofer, B. Lorbeer, N. Luz, F. Deinhardt, and M. Roggendorf. 1992. Prevalence of hepatitis C virus infections in dialysis patients and their contacts using a second generation enzyme-linked immunosorbent assay. Med. Microbiol. Immunol. 181:173-180.
23. Schneeberger, P. M., J. Vos, and W. C. van Dijk. 1993. Prevalence of antibodies to hepatitis C virus in a Dutch group of haemodialysis patients related to risk factors. J. Hosp. Infect. 25:265-270.
24. Seelig, R., M. Renz, C. Bottner, and H. P. Seelig. 1994. Hepatitis C virus infections in dialysis units: prevalence of HCV-RNA and antibodies to HCV. Ann. Med. 26:45-52.
25. Shakil, A. O., C. Conry-Cantilena, H. J. Alter, P. Hayashi, D. E. Kleiner, V. Tedeschi, K. Krawczynski, H. S. Conjeevaram, R. Sallie, and A. M. Di Bisceglie. 1995. Volunteer blood donors with antibody to hepatitis C virus: clinical, biochemical, virologic, and histologic features. The Hepatitis C Study Group. Ann. Intern. Med. 123:330-337.
26. Simon, N., A. M. Courouce, N. Lemarrec, C. Trepo, and S. Ducamp. 1994. A twelve year natural history of hepatitis C virus infection in hemodialyzed patients. Kidney Int. 46:504-511.
27. Stuyver, L., R. Rossau, A. Wyseur, M. Duhamel, B. Vanderborght, H. Van Hauverswyn, and G. Maertens. 1993. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J. Gen. Virol. 74:1093-1102.
28. Tanaka, E., K. Kiyosawa, Y. Nakatsuji, Y. Inoue, T. Miyamura, J. Chiba, and S. Furuta. 1993. Clinical significance of antibodies to nonstructural and core proteins of hepatitis C virus in posttransfusion hepatitis patients during long-term follow-up. J. Med. Virol. 39:318-324.
29. van der Poel, C. L., H. W. Reesink, E. P. Mauser-Bunschoten, R. H. Kaufmann, A. Leentvaar-Kuypers, R. A. Chamuleau, W. Schaasberg, E. Bakker, P. J. Exel-Oehlers, I. Theobalds, et al. 1991. Prevalence of anti-HCV antibodies confirmed by recombinant immunoblot in different population subsets in The Netherlands. Vox Sang. 61:30-36.
30. van Doorn, L. J., B. Kleter, L. Stuyver, G. Maertens, H. Brouwer, S. Schalm, R. Heijtink, and W. Quint. 1994. Analysis of hepatitis C virus genotypes by a line probe assay and correlation with antibody profiles. J. Hepatol. 21:122-129.
31. van Doorn, L. J., B. Kleter, L. Stuyver, G. Maertens, J. T. Brouwer, S. Schalm, R. A. Heijtink, and W. Quint. 1995. Sequence analysis of hepatitis C virus genotypes 1 to 5 reveals multiple novel subtypes in the Benelux countries. J. Gen. Virol. 76:1871-1876.
32. Vrielink, H., C. L. van der Poel, H. W. Reesink, H. L. Zaaijer, E. Scholten, L. C. Kremer, H. T. Cuypers, P. N. Lelie, and M. H. van Oers. 1995. Look-back study of infectivity of anti-HCV ELISA-positive blood components. Lancet 345:95-96.
33. Zaaijer, H. L., H. T. Cuypers, H. W. Reesink, I. N. Winkel, G. Gerken, and P. N. Lelie. 1993. Reliability of polymerase chain reaction for detection of hepatitis C virus. Lancet 341:722-724.